VA Erectile Dysfunction Claims: DC 7522 and SMC-K

What the VA Counts as Erectile Dysfunction

For VA purposes, erectile dysfunction is the loss of erectile power, meaning the inability to achieve or maintain an erection sufficient for satisfactory function. It is rated under 38 CFR 4.115b, diagnostic code 7522. The current title of the code is "Erectile dysfunction, with or without penile deformity," language set by the 2021 genitourinary rewrite.

The 0% Rating and SMC-K: Where the Compensation Actually Comes From

Under DC 7522, the schedular rating for erectile dysfunction is a fixed 0 percent. The reason a 0 percent diagnosis still matters is the cross-reference written into the regulation itself. Footnote 1 to the code states: "Review for entitlement to special monthly compensation under 3.350 of this chapter." The section-top note for the whole genitourinary table repeats the point: when a claim involves loss or loss of use of one or more creative organs, the rater must refer to 38 CFR 3.350 to determine whether the veteran may be entitled to special monthly compensation.

Erectile dysfunction is the classic loss-of-use-of-a-creative-organ scenario. Under 38 U.S.C. 1114(k) and 38 CFR 3.350(a), a veteran who, as a result of a service-connected disability, has loss or loss of use of a creative organ is entitled to special monthly compensation at level K, commonly called SMC-K.

The Board's published decisions show how central SMC-K is to this condition. Erectile dysfunction appears as the underlying condition in 2,653 special monthly compensation claims, of which 785 were granted, 1,030 denied, and 330 remanded, an approximate grant rate of 43 percent (published BVA decisions, SMC dataset 2018 to 2026). Of those ED-driven SMC claims, the overwhelming majority, 1,930, were at level K. Across all SMC-K decisions, the most-cited evidence was the VA examination (about 4,103 citations), followed by a private medical opinion (about 1,199) and a lay statement (about 1,042).

DC 7522 Rating Levels

The genitourinary schedule lists a single rating line for erectile dysfunction. There is no percentage ladder for severity of ED itself, the schedular value is fixed.

Because the schedular rating is 0 percent, the value of an ED claim is the SMC-K add-on described above, not a percentage that raises your combined rating. The only way a percentage above 0 attaches to the genitals themselves is through actual penile deformity rated by analogy, described below.

When a separate percentage can apply (penile deformity by analogy)

The Note immediately following DC 7522 states that a disease or traumatic injury of the penis resulting in scarring or deformity shall be rated under diagnostic code 7522. Where there is documented physical deformity of the penis, raters have at times assigned a separate compensable evaluation (commonly cited at 20 to 30 percent) by analogy to an anatomically similar code, in addition to considering SMC-K. This requires objective deformity in the record. Loss of erectile power without deformity remains 0 percent schedular plus SMC-K.

How Erectile Dysfunction Gets Service Connected

Direct service connection

Direct service connection for ED requires a current diagnosis, an in-service event, injury, or disease, and a medical nexus linking the two. Direct ED claims are uncommon, and the Board's data shows why: among classified service-connection denials for DC 7522, the dominant dispositive reason is a missing nexus. Of 2,207 classified service-connection denials, 1,429 turned on no nexus, 483 on no in-service event, and 295 on no current diagnosis (published BVA decisions). The missing medical link to service is the single largest reason these claims are denied.

Presumptive pathways

There is no direct toxic-exposure presumptive for erectile dysfunction itself. ED is not on any Agent Orange, burn pit, PACT Act, or Camp Lejeune presumptive list. According to VA.gov's Agent Orange page, the listed conditions include "Diabetes mellitus type 2," not ED.

Where presumptives matter for ED is indirectly. ED routinely reaches service connection by riding on a presumptive primary condition. A veteran can get Type 2 diabetes service connected presumptively (it is an Agent Orange presumptive), then claim ED as secondary to that diabetes. Hypertension (added as an Agent Orange presumptive under the PACT Act) and ischemic or coronary heart disease are additional presumptive primaries that frequently cause ED. See the Agent Orange presumptive page.

Secondary service connection (the main route)

Secondary service connection is by far the most common way ED is established. Under 38 CFR 3.310, a secondary claim requires a current diagnosis of ED and a medical nexus opinion stating that a service-connected condition (or a medication taken for it) caused or aggravated the ED. The Board's published decisions show the major pathways, ordered by volume:

• Secondary to diabetes (DC 7913): the single largest pathway. ED claimed as secondary to diabetes appears 917 times, granted at approximately 50 percent (published BVA decisions, n = 917). See the diabetes claims guide.
• Secondary to genitourinary cancer (DC 7528): 294 appeals, granted at approximately 65 percent (published BVA decisions, n = 294).
• Secondary to hypertension (DC 7101): 256 appeals, granted at approximately 59 percent (published BVA decisions, n = 256).
• Secondary to coronary artery disease (DC 7005): 78 appeals, granted at approximately 60 percent (published BVA decisions, n = 78). See the CAD claims guide.
• Secondary to major depressive disorder (DC 9434), often via medication side effects: 59 appeals, granted at approximately 79 percent (published BVA decisions, n = 59).

The winning pattern these decisions catalogue is consistent: a service-connected primary condition, plus a competent medical opinion tying the ED to that primary or to a medication taken for it. See secondary conditions and secondary vs aggravation.

Common Secondary Conditions

Secondary service connection runs in two directions. For erectile dysfunction, the high-value direction is what causes ED, because ED is almost always the downstream condition. The reverse direction (what ED itself causes) exists in the data but on much smaller numbers.

Conditions that cause ED (ED claimed as secondary to them)

This is the dominant direction and carries the larger samples. Each bar is the published BVA grant rate for ED claimed secondary to that condition, with the number of decisions below it:

Pyramiding and Rating Separately

The VA's pyramiding rules prevent paying twice for the same disability. For erectile dysfunction, pyramiding rarely becomes an issue, because the schedular rating is 0 percent and contributes nothing to the combined evaluation. The compensation, SMC-K, is a separate special monthly compensation amount layered on top of the combined rating rather than a percentage folded into it.

Two points follow from how the regulation is structured:

• The primary condition and the ED are rated separately: the underlying condition that caused the ED (diabetes, heart disease, depression, and similar) is rated under its own diagnostic code. The ED is rated 0 percent under DC 7522, and SMC-K is considered on top. These are distinct lines, not double-counting.
• Penile deformity, if present, is the only ED-side percentage: where a separate compensable evaluation is assigned by analogy for documented physical deformity, it reflects the deformity, not the loss of erectile power, which is already captured by the 0 percent line and SMC-K.

Evidence That Wins These Claims

The Board's published decisions for DC 7522 show a clear ordering of which evidence types are associated with the highest grant rates. The strongest single lever is a private nexus opinion.

• A private nexus opinion: approximately 85.4 percent of erectile dysfunction appeals were granted when a private nexus opinion was in the file, versus 39.4 percent without it (published BVA decisions, n = 711 with / 3,301 without). That is a difference of about 46 percentage points, the largest single factor in the data.
• A nexus letter (as an evidence type): among decisions citing a given evidence type, a nexus letter carried the highest grant rate, approximately 59 percent (published BVA decisions, n = 1,638). This was well above a VA examination at approximately 31 percent and service treatment records at approximately 25 percent.
• Medical literature: decisions citing supporting medical literature were granted at approximately 45 percent (published BVA decisions). Literature describing the mechanism (for example, diabetes-related vascular damage causing ED) supports a secondary theory.
• The prescription record: documentation of treatment for ED, such as PDE5 inhibitors (for example, sildenafil or tadalafil), vacuum devices, or injections, is core evidence of loss of erectile power and supports the SMC-K determination.
• The primary condition workup: when ED is claimed as secondary, the file for the service-connected primary (for example, diabetes labs, a cardiovascular evaluation, or a medication list showing a drug with ED as a known side effect) helps establish the causal link.
• A VA examination and service treatment records: these appear in the data at lower grant rates (approximately 31 percent and 25 percent respectively, published BVA decisions). They document the diagnosis and the timeline but, on their own, are weaker than a private nexus opinion.

Common Mistakes

Diagnostic Tests and the DBQ

No laboratory test changes the schedular percentage for ED, which is fixed at 0 percent. Testing serves a different purpose: to confirm the diagnosis, establish the etiology and nexus, and support SMC-K eligibility for loss of use of a creative organ. The following appear in the VA's evaluation process:

• The C&P examination using the Male Reproductive Organ Conditions DBQ: the VA Disability Benefits Questionnaire that captures ED is VA Form 21-0960J-2, available from VA.gov. See the DBQ guide.
• Physical examination of the penis, testes, and prostate: the DBQ physical-exam section documents any deformity, atrophy, or abnormality.
• Medical history of onset, progression, etiology, and treatment response: response to oral PDE5 inhibitors (such as sildenafil or tadalafil), injections, a vacuum device, or an implant is used to establish loss of erectile power.
• Review of the primary condition workup: when ED is claimed as secondary, this includes items such as diabetes labs (fasting glucose or HbA1c), a cardiovascular evaluation, or a medication list documenting drugs with ED as a known side effect.
• The International Index of Erectile Function (IIEF): a validated 15-item symptom questionnaire sometimes used clinically to characterize severity. It is not required for the 0 percent schedular rating but can support documentation.

Frequently Asked Questions